Direct Binding of Ledipasvir to HCV NS5A: Mechanism of Resistance to an HCV Antiviral Agent

• Hyock Joo Kwon ,

  * E-mail: HyockJoo.Kwon@gilead.com

  Affiliation Gilead Sciences, Inc., Foster City, California, United States of America

  ⨯
• Weimei Xing,

  Affiliation Gilead Sciences, Inc., Foster City, California, United States of America

  ⨯
• Katie Chan,

  Affiliation Gilead Sciences, Inc., Foster City, California, United States of America

  ⨯
• Anita Niedziela-Majka,

  Affiliation Gilead Sciences, Inc., Foster City, California, United States of America

  ⨯
• Katherine M. Brendza,

  Affiliation Gilead Sciences, Inc., Foster City, California, United States of America

  ⨯
• Thorsten Kirschberg,

  Affiliation Gilead Sciences, Inc., Foster City, California, United States of America

  ⨯
• Darryl Kato,

  Affiliation Gilead Sciences, Inc., Foster City, California, United States of America

  ⨯
• John O. Link,

  Affiliation Gilead Sciences, Inc., Foster City, California, United States of America

  ⨯
• Guofeng Cheng,

  Affiliation Gilead Sciences, Inc., Foster City, California, United States of America

  ⨯
• Xiaohong Liu,

  Affiliation Gilead Sciences, Inc., Foster City, California, United States of America

  ⨯
• Roman Sakowicz

  Affiliation Gilead Sciences, Inc., Foster City, California, United States of America

  ⨯